Ari Ristimäki
- Pharmacology top 1%
- Molecular Biology
- Genetics top 5%
- Cancer Research top 10%
- Surgery
- Co-authors
- Heidi JänkäläP. SipponenMatti HärkönenKirsi NarkoOlli RitvosAlexandra ThielCaj HaglundJohan Lundin
- Topics
- Inflammatory mediators and NSAID effects (5 papers)Estrogen and related hormone effects (4 papers)Esophageal Cancer Research and Treatment (3 papers)
- Cited by
- PharmacologyCancer ResearchGenetics
- Partner nations
- FinlandSwedenUnited States
In The Last Decade
Ari Ristimäki
14 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 89
- Pharmacology 690
- Molecular Biology 565
- Genetics 457
- Cancer Research 305
- Surgery 276
Countries citing papers authored by Ari Ristimäki
This map shows the geographic impact of Ari Ristimäki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ari Ristimäki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ari Ristimäki more than expected).
Fields of papers citing papers by Ari Ristimäki
This network shows the impact of papers produced by Ari Ristimäki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ari Ristimäki. The network helps show where Ari Ristimäki may publish in the future.
Co-authorship network of co-authors of Ari Ristimäki
This figure shows the co-authorship network connecting the top 25 collaborators of Ari Ristimäki. A scholar is included among the top collaborators of Ari Ristimäki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ari Ristimäki. Ari Ristimäki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 6 | |
| 7 | 7 | |
| 8 | 50 | |
| 9 | 184 | |
| 10 | 129 | |
| 11 | 65 | |
| 12 | 35 | |
| 13 | 81 | |
| 14 | 72 | |
| 15 | 36 | |
| 16 | Expression of cyclooxygenase-2 in human gastric carcinoma.breakdown → | 714 |
| 17 | 111 | |
| 18 | 28 |
About Ari Ristimäki
Ari Ristimäki is a scholar working on Pharmacology, Agronomy and Crop Science and Endocrinology, having authored 18 papers that have together received 1.5k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (5 papers), Estrogen and related hormone effects (4 papers) and Esophageal Cancer Research and Treatment (3 papers). The work is most often cited by research in Pharmacology (690 citations), Cancer Research (305 citations) and Genetics (457 citations). Ari Ristimäki has collaborated with scholars based in Finland, Sweden and United States. Frequent co-authors include Heidi Jänkälä, P. Sipponen, Matti Härkönen, Kirsi Narko, Olli Ritvos, Alexandra Thiel, Caj Haglund, Johan Lundin, Karri Paavonen and Mika Laitinen. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Cancer Research and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.